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Numerous  attempts  have  been  made  by previous  workers  to  demonstrate 
the presence of tumor-specific antibodies  in sera obtained from animals immu- 
nized  with  preparations  of  human  cancers  (1-8).  Such  demonstrations,  if 
consistently reproducible,  would indicate  the existence in human cancer tissue 
of unique  homologous antigens  not present  in normal  tissue,  and  might  thus 
lead to a  better understanding  of the nature of the neoplastic process. 
One  of the  techniques  frequently  employed in  this  type  of investigation  is  the 
absorption of antitumor antiserum with normal tissue in order to remove antinormal 
components of the antiserum (1, 9, 10). Any residual antibody activity in the absorbed 
antiserum which is directed against tumor material is then considered to be tumor- 
specific.  However, in interpreting  the  results  of absorption  experiments,  little  con- 
sideration has been given to the possibility that tumor-specific antibodies may have 
been removed or inactivated by normal tissue components similar to, but not identical 
with, the tumor antigens which initially stimulated the antibody production. 
Another, more recent, technique for the demonstration of tumor-specific antibodies 
is the utilization of animals rendered immunologically tolerant to normal tissues during 
neonatal life (11). These tolerant animals are then immunized with tumor preparations 
of the same donor species.  In those cases where adequate suppression of the immune 
response to normal tissue components has been achieved, immunization of the tolerant 
animals  with  tumor preparations  during  adult  life  has  led  to  the  development  of 
antibodies  apparently  specific  for  the  tumor  (12-21).  Nevertheless,  the  reported 
studies of human cancer employing acquired  immunological tolerance  (17-21)  have 
left certain points unclear. In particular, the greatest cause for possible misinterpreta- 
tion of results has been the failure to use the same donors as the source of normal and 
tumor material.  Instead, the normal tissue has come from non-cancerous individuals 
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or from cadavers free of malignant neoplastic disease.  Despite the fact that normal 
individual-specific antigens  may  have been  diluted  out  in  a  tissue  pool,  it  is  con- 
ceivable that some  of  the antibodies labeled  "tumor-specific"  in these experiments 
were, in reality, the result of individual antigenic differences between donors. 
The objectives of the present study were (a) to attempt to demonstrate the 
presence of tumor-specific  antigens in carcinomata of the human colon utilizing 
both the absorption and immunological  tolerance techniques with normal and 
tumor tissues obtained from the same human donors; and (b) to compare the 
sensitivity and reliability of each of these two methods for the immunological 
demonstration of unique tumor constituents. Neither of these two objectives 
has been previously attempted. 
Materials and Methods 
The Preparation of Normal and Tumor Tissue Extracts.--The  source of tissue in this series 
of experiments was human colon. The specimens removed surgically for primary adenocarci- 
noma of the colon, were taken from various sites ranging from the cecum to the rectosigmoid 
junction.  The  diagnosis was  confirmed postoperatively by histological examination in  all 
cases. Carcinoma of the colon was chosen for study because it almost never extends submucos- 
ally more than 6 to 7 cm on either side of the tumor visible in the gross (22). Thus, portions 
of the specimen more than 7 cm proximal or distal to the cancerous growth could he considered 
normal tissue. In this way the problem of individual-specific antigenic differences  between the 
normal and tumor tissue pools was overcome. Random microscopic examination of the areas of 
tissue considered to be normai failed to reveal the presence of cancer ceils at any time. The 
7 cm portion of tissue normal in the gross on either side of the neoplasm was removed and dis- 
carded. Only the central, obviously cancerous portion was used as tumor tissue for extraction. 
Normal tissue extracts were prepared from sections of colon more than 7 cm distant from the 
visible edges of the tumor. 
Two pools of tissue, each consisting of ten specimens, were collected and extracted by some- 
what different methods. The extraction procedure foUowed for each pool, however, wasidentical 
for the normal and tumor tissues except that the two aiiquots were stored and handled apart 
from one another in order to avoid contamination. Donors of all major blood groups were 
represented in each pool. In addition to the two pools of tissue, twelve individual specimens 
which had not been included in either pool were extracted by the procedure used for pool I 
tissues. 
Extraction Procedure for Pool/.--The mucosal fining of each specimen was stripped as 
cleanly as possible from the underlying tissue. In order to make the normal and tumor tissue 
extracts as similar as possible, small amounts of muscularis mucosae and stroma were included 
in the normal tissue strips because the tumor material invariably contained these structural 
components. The tissue strips were cut into small pieces with stainless steel scissors and washed 
clean in cold physiological saline solution. The finely cut pieces were then put through a hand- 
operated stainless steel tissue grinder fitted with a fine sieve which held back a large proportion 
of the connective tissue elements. The resultant mince was suspended in 0.03 ~r phosphate- 
saline buffer at pH 8.0 in proportions of 1 gm wet weight of mince to 4 ml of buffer, and then 
homogenized in 120 ml aliquots in a Virtis "45" homogenizer at 45,000 ~M for 15 minutes at 
4°C. The homogenate was centrifuged at 1000 g for 1 hour at 4°C, the supernatant decanted 
and then stored in sterile bottles. The sediment was resuspended in the phosphate-safine buffer 
(2 ml per gm of the initial wet weight of the mince), thoroughly stirred and then exposed in 10 PHIL GOLD  AND  SAMUEL  O. I~'REEDMAN  441 
ml aliquots  to ultrasonic  vibration  at 38.5 kc per second for 3 minutes in a fixed  frequency 
Sonogen ultrasonic  transducer.  The ultrasonated  suspension was  again  centrifuged  as  outlined 
above and the supernatant  added to  that obtained  after  the initial  centrifugation.  The pooled 
supernatants made up the tissue  extracts  of  pool I. Bacteriological  cultures were performed 
and  both  the  normal  and tumor  tissue  extracts  showed very light  growths of  Escher/,h/a Coli. 
Aftcr the addition of streptomycin in quantities  of 15/~g/ml, repeated cultures of the ex- 
tracts  revealed no bacterial growth. Kjeldahl determinations were performed on the ex- 
tracts  to  determine  protein  content.  Finally,  the  pools  were divided into I0  ml aliquots,  quick 
frozen  in  a dry  ice-alcohol  bath  and stored  at -20°C as  stock material  for  the  procedures out- 
lined  below. 
Extraction Procedure  for Pool//.--The procedure followed for pool II was identical with 
that of pool I until the stage where the supernatants of the two centrifugation steps were com- 
bined. From this stage the procedure differed as follows: 
The pooled supernatants were again subjected to centrifugation, but this time in a Beckman 
model "L" preparative ultracentrifuge at 22,000 g (Rav) for 32 minutes (predpitation time). 
The supernatant was decanted and lyophylized. Prior to use the powdered material was recon- 
stituted with distilled water and filtered through 0.22 # Millipore filters (type HA) into sterile 
bottles. Bacteriological cultures of the filtrates were invariably sterile. Kjeldahl determina- 
tions were performed and the protein concentrations adjusted according to needs prior to use. 
Immunization of Adult Rabb/ts.--Twenty adult, male, New Zealand white rabbits weighing 
2.0 -4- 0.2 kg were divided into 5 groups of 4 each. The different groups were immunized with 
the following materials: normal tissue extract of pool I  (NI), tumor tissue extract of pool I 
(1"1), normal tissue extract of pool II CN2), tumor tissue extract of pool II (T2), and pooled hu- 
man plasma (P). (The pooled human plasma was obtained from 30 normal donors representing 
all major blood groups.) 
The injections, given twice weekly for 4 weeks, contained 3 mg of protein in 0.6 ml of tissue 
extract or plasma emulsified in an equal volume of complete Freund's adjuvant. Injections of 
0.1 to 0.2 ml were given into a  foot-pad and the remainder intramuscularly into the flank. 
Twelve days following the last injections the animals were bled from their marginal ear veins 
and the sera obtained from each group was pooled separately for testing. 
Induction of Immunological Tolerance to Normal Human Colon Extract in Neonatal Rabbits.-- 
Six mature, New Zealand white female rabbits were purchased  at 2 weeks of pregnancy. These 
animals were kept isolated and were eared for by the same individual at all times. Within 
29 4- ! days of fertilization 40 young rabbits were born to the 6 does. Of these, 24 (60 per cent) 
survived until the completion of the experiment. Within 12 hours of birth, 19 of the neonatal 
animals  that  eventually survived were given  subcutaneous  injections  of  normal  tissue 
extract of pool I  (containing 10 nag of protein) together with  12 mg of pooled human  plasma 
and 3 mg of human hemoglobin. These injections were repeated  every 12  hours  for a  total 
of 4 doses. The injections of human blood components were given in order to increase the pos- 
sibility of induction of tolerance to (a)  blood components contaminating the tissue extracts, 
and (b) tissue components containing antigenic determinants similar to those of plasma pro- 
teins. Further subcutaneous injections of normal tissue extract alone (containing 5 mg of pro- 
tein) were given at 3,  7,  10,  14, 21, 28,  55, and 60 days of age. These animals were bled at 
72 days of age to determine whether an immunological response had been obtained against 
normal tissue. Five of the neonatal animals which served as controls received no injections 
during this period of the experiment. 
Immunization of the Apparently Tolerant Rabbits.--At  80, 84, 87, 90, and 140 days of age,  14 
of the 19 survivors of the experimental group received 1 ml injections of tumor tissue extract 
of pool I  (containing 5 mg of protein)  emulsified in an equal volume of complete Fretmd's 
adjuvant. Injections of 0.1 to 0.2 ml were given into a foot-pad and the remainder intramus- 442  TU3IOR-SI~ECIYIC ANTIGENS 
cularly into a flank. Five animals of the experimental group and the 5 controls received similar 
injections of normal tissue extract containing 5 mg of protein. All the animals were bled from 
their marginal ear veins at 100 and 150 days of age and the sera stored for testing. 
Techniques of Antibody Demonstration.--The Ouchterlony technique (23) of double diffusion 
in agar gel was performed in 1 per cent agar-in-saline with merthiolate added as a preservative 
to a final concentration of 1/10,000. The patterns were cut in the gel plates so that the central 
and peripheral wells were spaced 1.0 cm apart. Each well was filled with 0.15 ml of test material 
on one occasion only. The antigen concentration used was 10 mg protein per ml in all  cases 
unless otherwise specified.  Initial incubation of the plates was carried out in a  moist environ- 
ment at 37°C for 24 hours to encourage diffusion of materials from the wells.  Patterns were 
then allowed to develop in the same humid atmosphere at 25°C for 7 days. 
Immunoelectrophoresis (23) was performed in perspex molds filled to a depth of 2 mm with 
1 per cent agar gel in either 0.1 ~s tris buffer at pH 8.6 or in 0.1 ~r acetic acid-acetate buffer 
at pH 4.0. The usual pattern consisting of a central trough with a weU on either side was cut 
in the gel. The wells were filled with 0.05 mi of the test antigens and subjected to electrophoresis 
at 6 to 7 v per can for 90 minutes in the same buffer system used to prepare the agar gel. The 
plate was then removed from the electrophoresis apparatus and the trough filled  with test 
antiserum. The precipitin patterns were allowed to develop in a moist environment at 25°C for 
7 days. 
Hemagglutination reactions were carried out by a modification of the technique described 
by Sehon (24) in which antigen is covalently coupled to rabbit erythrocytes with bis-diazotized 
benzidine (BDB). In ail tests performed, the erythrocytes were sensitized by mixing aiiquots 
of either the normai or tumor tissue extracts (containing 1.5 mg of protein dissolved in 3 ml 
of saline) with 0.1 ml of a 50 per cent suspension of washed rabbit red cells and 0.5 ml of BDB- 
phosphate buffer solution at pH 7.3. In certain tests the technique was slightly modified by 
adding the BDB to the erythrocytes immediately before rather than after the addition of the 
antigen. 
Passive cutaneous anaphylaxis (PCA) reactions were performed in mice by a modification 
of the procedure of Ovary (25) as described by Halperu et al. (26). Intracutaneous injections of 
0.02 ml of test serum were followed in 3 hours by intravenous injections of a mixture containing 
0.3 ml of 0.7 per cent solution of Evan's blue (T1824) and 1 mg of the test antigen protein. 
Reactions were read 30 minutes after the intravenous injection by sacrificing the animal and 
measuring the largest diameter of the subcutaneous dye spot. The following grading system 
was used: :t:, less than 4 mm; +, 4 to 8 ram; ++,  8 to 12 ram; +++,  12 to 16 mm; and 
++++,  greater than 16 mm. If a positive reaction was observed the titer was obtained by 
determining the highest dilution of antiserum which gave a positive (+) reaction. 
In  the  immunofinorescent studies,  antiserum-ffuorescein conjugation  was  performed as 
described by Rinderknecht (27) and non-specific staining material removed by the technique 
of Goldstein et al. (28). The conjugates were used only if they fulfilled the criteria of specificity 
outlined by Kaplan (29).  Small blocks of tissue to be stained and examined were snap-frozen 
at -  40°C and frozen sections, 6 to 8 it in thickness, were cut on a Lipshaw electric cryostat and 
microtome model 1500. Sections were thawed on microscopic slides at room temperature and 
fixed in ether-aicohol (equal parts) for 10 minutes at room temperature followed by incubation 
in 95 per cent alcohol for 30 minutes at 37°C. The sections were then dried in air and stored for 
2 to 24 hours at 4°C until used. The indirect or "sandwich technique" of Coons (30) was carried 
out using sheep anti-rabbit "y-globulin  antiserum  t conjugated to fluorescein (27). The sections 
to be studied were first covered with a few drops of unconjugated test antiserum and incubated 
1 The sheep anti-rabbit 3,-globulin antiserum was  kindly provided by  Dr.  L.  Gyenes of 
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in a moist environment at 37°C for 20 minutes. The sections were then washed in changes of 
buffered saline at pH 7.3 for 20 minutes at which time the staining and washing procedure was 
repeated with the fluorescein-conjugated sheep anti-rabbit "y-globulin antiserum. The  sections 
were dried in room air and inspected by ultraviolet fluorescence microscopy using a  Leitz dia- 
lux fluorescence microscope with a high vacuum Osram burner HBO 200 as the illuminating  sys- 
tem. Ultraviolet filters 4 mm UG1 and/or 2 mm UG2 were used in conjunction with a protec- 
tive  filter  system.  Ocular  magnification  10 was used permanently with various  objectives 
(magnification  expressed as ocular X objective). Photomicrographs were taken with a Leica M2 
camera and adapter using Kodak plus X  black and white film. 
Absorption and Dilution of Antiserum.--In  all  the absorption  reactions performed,  the 
absorbing antigen was in solution rather than in the dry state. In order to obtain uniformity of 
results all antisera, whether absorbed or not, were diluted to four times their original volume 
before the performance of any test. In the case of the hemagglutination reactions the dilutions 
noted are those of whole antiserum prior to the addition of any absorbing medium. In those 
cases  where  a  heavy precipitate  formed  during the absorption procedure,  the sample was 
centrifuged at 2000 ge~r for 15 minutes and the clear supernatant used in the various tests. 
Preliminary Characterization of Antigens and Antibodies.--The method of Winzler et al. (31) 
for extraction of mucoprotein with 0.6 •  perchloric acid was applied to the antigen preparation 
of pool I  (T1). The filtrate prepared by this method was dialyzed against buffered saline at pH 
7.3 for 24 hours. The antitumor antisera prepared by absorption and by immunological toler- 
ance were each fractionated by column chromatography on sephadex  G-200  (32)  and were 
each treated with mercaptoethanol according to the technique of Deutsch and Morton (33). 
RESULTS 
Experiments Employing Non-Tolerant Rabbits and the Absorption Technique.- 
Text-figs.  1 and 2  show the  Ouchterlony patterns developed  between  the anti- 
TEXT-Fro.  I  TEx¢-Fm. 2 
TExT-Fro.  1.  Center, N1,  (A) nl,  (B) tl,  (C)  control serum from  non-immunized rabbits, 
(D) p. A marked degree of cross-reactivity is shown by the three antisera against  the normal 
antigenic mixture. 
TExt-FIG.  2.  Center, T1,  (A) nl,  (B) tl,  (C)  control serum from non-immunized rabbits, 
(D) p.  A marked degree of cross-reactivity is shown by the three antisera against the tumor 
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gens of pool I  (N,, normal tissue extract of pool I,  T1,  tumor  tissue  extract  of 
pool I, and P, pooled human plasma)  and their corresponding antisera  (n,,  tl, 
and p respectively) (Table I). As expected, a multiplicity of precipitin bands ap- 
peared in each antigen-antibody system.  It is  apparent  from examining these 
patterns  that  a  high  degree  of  antigenic  cross-reactivity  exists  between  the 
normal and tumor tissue extracts  and their respective  antisera.  It will also be 
noted  that  both the  normal and  tumor extracts  contained  many components 
which produced precipitin lines with anti-human plasma antiserum. Absorption 
of each of the three antisera  (nl, h, and p) was then carried out with an excess 
of both N1  (2  ml containing  10 mg of protein)  and  P  (1  ml  of whole human 
plasma)  so that complete inhibition  of precipitin band formation was  achieved 
TABLE  I 
Summary of Symbols used in the Text and for Figure Captions 
Symbols 
N1, N2 
T1, T2 
P 
nl, n2 
tl, t2 
p 
trs-150 
-abs 
Explanation  of symbols 
Extracts of normal colonic tissue of pool I and pool II respectively. 
Extracts of colonic tumor tissue of pool I and pool II respectively. 
Pooled human plasma. 
Rabbit antisera against N1 and N2 respectively. 
Rabbit antisera against TI and T2 respectively. 
Rabbit antiserum against P. 
Pooled antisera  of rabbits  rendered  almost  completely  tolerant  to N1 and 
then immunized with T1 (at  150 days of age). 
This suffix following the symbol for an antiserum  indicates that it has been 
absorbed with an excess of normal colonic tissue extract and pooled human 
plasma. 
against the absorbing antigens.  The anti-tumor tissue antiserum  (h) so treated 
(and denoted henceforth as tl-abs), gave a single band against T1. However the 
absorbed  nl  (nrabs)  and  absorbed  p  (p-abs)  failed  to do  so  (Text-fig.  3).  In 
order to determine whether the bacterial flora of the bowel or the streptomycin 
used to sterilize the extract were playing a  role in the production of the appar- 
ently tumor-specific band, further absorption of tl-abs was carried out with an 
ultrasonated  extract  of  pooled  bowel  flora  to  which  streptomycin  had  been 
added.  Such  treatment  failed  to alter  the  single band between  T1 and  t,-abs. 
Similarly,  absorption of t,-abs  with  human fibrinogen failed to alter  the band 
formation. However, the addition of T~ (0.5 ml containing 5 mg of protein)  to 
h-abs prior  to performing  the  Ouchterlony reaction,  specifically inhibited  the 
appearance of the precipitin band between T~ and h-abs. 
The  immunoelectrophoretic  patterns  obtained  between  the  tissue  extracts 
N~ and T1 and the anti-tumor  tissue antiserum  (tl) before and after inhibition 
with both Nt and P are shown in Text-figs. 4 and 5 respectively (electrophoresis PHIL  GOLD AND  SAMUEL O.  FREEDMAN  445 
carried out in tris buffer at pH 8.6). As with the Ouchterlony patterns numerous 
bands appeared against both antigenic mixtures prior to absorption, but only a 
single  band  remained  between  T1  and  tl-abs after  the  absorption  procedure. 
The antigen taking part in this precipitation showed little or no mobility at the 
buffer pH of 8.6.  However,  when  the  immunoelectrophoretic studies between 
T1 and tl-abs were repeated with acetic acid-acetate buffer at pH 4.0, the single 
band was found nearer the negative pole. 
The  results of the  hemagglutination reactions are listed in Table II. It will 
be noted that both nl and tl showed very high titers against their homologous 
antigens as well as a  high degree of cross-reactivity between normal and tumor 
TExT-FIG. 3.  Center, T1,  (A) nl-abs, (B)  tl-abs, (C) absorbed control serum  from non- 
immunized animals,  (D) p-abs. The only remaining band is seen between T1 and tl-abs. 
TExT-FIG. 4.  Immunoelectrophoresis  in agar gel (tris buffer at pH 8.6). Upper well, N1, 
lower well, T1, trough,  tl. A multiplicity of bands is observed between the antiserum and both 
antigenic mixtures. 
TExT-FIG. 5.  Immunoelectrophoresis  in agar gel (tris buffer at pH 8.6). Upper well, N1, 
lower well, T1, trough,  tl-abs. A single residual band is seen between T1 and tl-abs. 446  TUMOR-SPECIFIC  ANTIGENS 
tissues.  Following  the  absorption  procedures,  especially,  the  titers  obtained 
were markedly dependent upon the manner in which the erythrocyte sensitiza- 
tion was performed.  If T1 was coupled to  the  rabbit  red cells  by mixing the 
antigen with  the erythrocytes prior  to the addition of BDB, negative results 
were  obtained  with  h-abs.  However,  if  the  red  cells  and  BDB  were  mixed 
immediately before the addition of the antigen T~,  a  relatively high titer was 
obtained between T1 and  ti-abs.  Regardless of the method of sensitization  of 
the  erythrocytes,  negative  results  were  obtained  between  N~  and  ni-abs  or 
h-abs; and between TI and trabs further absorbed with T1. 
TABLE II 
Immunological Reactions with Sera of Non-Tolerant Animals 
Antigen 
N1 
T1 
N1 
T1 
N1 
T1 
N1 
T1 
T1 
Absorbing antigens 
m 
m 
NI+  P 
NI+P 
NI+ P 
NI+P 
N1 +  P +  T1 
Hemagglutination 
Titer A* 
1.64 X  106 
1.64 X  106 
0.82 X  106 
1.64 X  106 
0 
0 
0 
0 
0 
Titer B~ 
13.10 X  106 
6.55  X  106 
6.55  X  106 
13.10 X  10  ~ 
0 
0 
0 
0.20  X  106 
0 
PCA 
Skin reaction 
++++ 
++++ 
++++ 
++++ 
0 
0 
o 
++ 
o 
Titer§ 
128 
128 
128 
128 
16 
* Hemagglutination titer observed when erythrocytes were sensitized by the addition of 
BDB after mixing red cells with antigen. 
Hemagglutination titer observed when erythrocytes were sensitized by the addition of 
BDB before mixing red cells with antigen. 
§ Reciprocal of the highest dilution of antiserum giving a positive (+) PCA reaction. 
The results of passive cutaneous anaphylaxis (PCA) experiments  (Table II) 
correlated well with those obtained by agar gel diffusion and hemagglutination. 
High degrees of reactivity and cross-reactivity were observed between normal 
and tumor tissue extracts and their respective antisera. Following the absorption 
of the antisera with N1 plus P,  the only remaining positive reaction was that 
of tl-abs  challenged with  T1.  This  reaction  could be  inhibited  specifically by 
absorbing h-abs with T1 prior to injection. 
Comparison  of  Results  Obtained  in  Non-Tolerant  Rabbits  with  Antigens  of 
Pool I,  Pool II,  and  Twelve  Individual  Specimens  of Adenocarcinoma  of  the 
Colon.--The Ouchterlony patterns obtained with pool II antigens (N2 and T2) 
and their homologous antisera  (n2 and t2 respectively) are shown in Text-figs. 
6 and 7). The patterns are similar to those observed with pool I materials (Text- 
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with an excess of both N~  (2 ml containing  10 mg of protein)  and P  (1 ml of 
whole human plasma) the only antigen-antibody combination which was found 
to produce precipitation in agar gel was T2 against t2-abs (Text-fig. 8). It will be 
noted  that  a  single  precipitation  band  was  obtained.  In  order  to  determine 
whether  or not  the  same antigen-antibody combinations were responsible for 
the  tumor-specific bands  obtained in  the  agar gel studies  of both pool I  and 
pool II, Ouchterlony reactions were carried out using T1 and T~ against tl-abs 
(Text-fig. 9) and T1 and T~ against t2-abs (Text-fig. 10). In both cases reactions 
of identity were obtained. 
TExT-Fro. 6  TExT-Fro. 7 
TExT-Fro. 6.  Center, N2,  (A) n2,  (B) t2,  (C) control serum from non-immunized rabbits, 
(D) p. A marked degree of cross-reactivity is shown by the three antisera against the normal 
antigenic mixture. 
TEXT-FIG. 7.  Center, T2, (A) n2,  (B) t~, (C) control serum from non-immunized rabbits, 
(D) p. A marked degree of cross-reactivity is shown by the three antisera against the tumor 
antigenic mixture. 
Further  adsorption  of tl-abs and  tz-abs on  their  corresponding lyophylized 
normal  tissue  extracts  (100  mg of extract  protein/ml  of antiserum)  prior  to 
testing failed to change the patterns illustrated in Text-figs. 9 and 10. Similarly, 
increasing  the  protein  concentrations  of  both  the  normal  and  tumor  tissue 
extracts from 10 mg protein/ml  to 40 nag protein/ml during the  reaction did 
not alter the appearance of the band formation. 
Immunoelectrophoretic studies of N2 and T2 against t2-abs (in tris buffer at 
pH 8.6) showed the development of a single band between T2 and ts-abs (Text- 
fig.  11).  The reactive antigen like that of T1 against tl-abs showed little or no 
mobility at pH 8.6 (compare with Text-fig. 5). 
When the normal tissue extracts of the twelve individual specimens were sub- 
jected  to  double  diffusion  in  agar  gel against  tl-abs and  t~-abs, no  precipitin 
band  formation  was  observed.  However,  when  the  tumor  extracts  of  these 448  TUMOR-SPECIFIC  ANTIGENS 
specimens were tested against either ti-abs or t~-abs, it was found that each of 
the twelve tumor extracts formed single bands against both antiserum prepara- 
tions. The twelve precipitin bands thus formed showed reactions of identity be- 
tween  themselves and  with  the  pooled tumor  extract preparations T~  and T2 
TExT-FIG. 8.  Center,  T2,  (A) n2-abs, (B)  t2-abs, (C)  absorbed control serum  from non- 
immunized rabbits, (D) p-abs. The only remaining band is seen between T2 and t~-abs. 
TEXT Fro. 9  TEXT Fro. 10 
TEx'r-Fm. 9.  Center,  tl-abs, (A) T1,  (B) T2,  (C) N1,  (D) N2. The bands formed between 
tl-abs and each of the two tumor antigenic mixtures show a reaction of complete identity. 
TExT-FIG. 10.  Center,  t2-abs, (A) T1, (B) T~, (C) N1, (D) N2. The bands formed between 
t2-abs and each of the two tumor antigenic mixtures show a reaction of complete identity. 
(Text-fig.  12).  The  results  obtained against tl-abs were  identical to  those  ob- 
tained  against  t2-abs.  Furthermore,  when  the  tumor  extract  of  any  of  the 
twelve individual specimens was used  to further  absorb  tl-abs or t2-abs, there 
was specific inhibition of band  formation against T1  and  T2. 
Experiments with Rabbits Rendered Tolerant to Normal Tissue.--Sera obtained 
at 72 days of age from the animals receiving injections of N1 from birth produced 
no  precipitin  bands  when  reacted  against  N1  in  agar  gel.  These  tests  were 
repeated  with  sera  obtained  at  100  days  of  age.  (The  experimental  group PHIL  GOLD  AND  SAMUEL  O.  FREEDMAN  449 
received its initial immunizing injections of T1 at 80 to 90 days). At this time 
each of the 14 animals of the experimental group showed a  single band against 
N1 and  three  bands  against  T1  (Text-fig.  13).  A  form of split  and/or  partial 
tolerance  (34,  35)  to  normal  tissue  had  thus  been  induced  in  these  animals. 
The  first control group which  had  received N1 injections  from birth  and had 
been given the  same material  between  80  and  90 days of age also showed  a 
TEXT-FIG. 11.  Immunoelectrophoresis  in agar gel (tris buffer at pH 8.6). Upper well, N2, 
lower well, T2, trough, t2-abs. A single band is seen between T2 and t2-abs. 
TExT-FIG. 12.  Center, t2-abs, (A) T1, (B) T2,  kC-H) tumor extracts of six of the  twelve 
individual specimens of human colonic adenocarcinoma. Reactions of complete identity  are 
seen between all  the precipitin bands which formed. Identical  reactions were obtained 
with  the  other  six specimens. 
single  band  against  N1.  The  non-tolerant  control  group  which  received  its 
initial injections of N1 between 80 to 90 days of age showed a number of bands 
against N1 at 100 days (Text-fig. 14). 
At 150 days, the serum of each of the animals of the experimental group was 
found to form two precipitin bands against N1 and six bands against T1 (Text- 
fig.  15).  Split  and/or  partial  tolerance  had  thus  been maintained  toward  the 
normal tissue extract.  Because of the similarity of the patterns obtained with 
each of the individual  animal sera, the sera were pooled for the remainder of 
the tests performed and will be referred to henceforth as trs-150. Absorption of 
trs-150 with human fibrinogen and an ultrasonated extract of bowel flora con- 
taining streptomycin failed to alter the pattern described above. The Ouchter- 450  TUMOR-SPECIFIC  ANTIGENS 
lony patterns  produced by sera  from the  two control groups were  similar  to 
those  seen  at  100 days except  that  sera from the  animals  of the  group that 
received only N1 from birth  now produced two rather  than one band against 
N1 (Text-fig. 16). 
The  results  of the  hemagglutination reactions  of the  150  day bleeding  are 
shown in Table  III. Once again much greater sensitivity was obtained  when 
TEXT-FIG. 13.  (A) N1, (B) T1, (C) Pooled antisera of rabbits showing split and/or partial 
tolerance to N1 at 100 days of age. Only a single band developed against the normal anti- 
genic mixture whereas three bands were formed against the tumor extract. 
TExT-FIG. 14.  (A)  Pooled antisera of control group (100 days of age) which received 
initial injections of N1 between 80 to 90 days of age, (B)  Pooled antisera of control group 
(100 days of age) injected with N1 from birth, (C) N1. 
the rabbit erythrocytes were sensitized by mixing the BDB with the red cells 
immediately before the addition of antigen.  Much higher titers were observed 
when trs-150 was reacted with red cells sensitized with T1 than those sensitized 
with N1. 
The  PCA  reactions  (Table  III)  again  correlated  well  with  the  results  of 
double  diffusion  in  agar  and  hemagglutination  experiments.  Sites  sensitized 
with trs-150  gave a  ++++  reaction when challenged with T1 as  compared 
to a  ±  reaction when challenged with NI. 
Comparison  of  Results  Employing  the  Absorption  Technique  with  Those 
Utilizing  Tolerance.--The  precipitin  pattern  obtained  by  the  absorption 
technique is compared to that developed by the tolerance method in Text-fig. 
17. The single  tumor-specific band between T1 and tl-abs showed a reaction of 
identity with two of the bands formed between T1 and trs-150.  Similar reactions PHIL  GOLD AND  SAMUEL  O.  FREEDMAN  451 
TExT-FIe.  15.  (A)  N1,  (B)  TI,  (C)  trs-150.  Accompanying drawing  shows  reactions of 
identity not well shown in the photograph. Two bands developed against the normal anti- 
genic mixture, but six bands developed against the tumor extract. 
TExT-FIG.  16.  (A)  Pooled  antisera of  control  group  (150  days  of  age)  which  received 
initial injection of N1 between 80 to 90 days of age.  (B) Pooled sera of control group  (150 
days of age) injected with NI from birth. (C) Nt. 
TABLE  III 
Immunological Reactions  wittt Sera o/Tolerant Animals  (trs-150) 
Antigen  Antiserum 
N1  trs-150 
T1  trs-150 
N1  trs-150 
T1  trs-150 
T1  trs-150 
Absorbing 
antigen 
N1 
N1 
T1 
Hemagglutination 
Titer A* 
3200 
640O 
0 
0 
0 
Titer B* 
25,600 
1.64  X  106 
0 
0.20  )<  106 
0 
PCA 
Skin reaction 
++++ 
0 
++ 
0 
Titer§ 
64 
16 
* Hemagglutination titer observed when erythrocytes  were sensitized by the addition of 
BDB after mixing red cells with antigen. 
:~ Hemagglutination titer observed when erythrocytes were sensitized by the addition of 
BDB before mixing red cells with antigen. 
§ Reciprocal of the highest dilution of antiserum giving a positive (+)  PCA reaction. 452  TUMOR-SPECIFIC ANTIGENS 
of identity were present for the two bands formed between Ni and trs-150 and 
for  two  of  the  six bands between T1  and  trs-150.  Therefore,  two  of  the  six 
precipitin lines produced by T1 and trs-150 have no counterparts in the zones 
between the other wells. 
When trs-150 was absorbed with an excess of N~  (1  ml containing 5  mg of 
protein) and reacted in agar gel with Ti (Text-fig.  18),  two bands remained. 
Both of these bands gave a  reaction of identity with the tumor-specific bands 
TExT-FIG. 17.  Comparison of results obtained by the tolerance and absorption  technique 
(A) T1,  (B)  N1,  (C) trs-150 (D)  tl-abs. Accompanying drawing shows reactions of identity 
not well shown in the photograph. It can be seen that two of the six bands between T1 and 
trs-150 have no counterparts in the areas between the other reactant wells. 
TExT-FIG. 18.  (A) tl-abs, (B) trs-150 absorbed with N1, (C) t~-abs, (D) T1. The two bands 
formed between T1 and trs-150 absorbed with N1 show reactions of identity with the appar- 
ently single bands formed between T1 and both tl-abs and t2-abs. PHIL  GOLD  AND  SAMUEL  O.  FREEDMAN  453 
obtained between T1 and tl-abs and between TI and  t2-abs.  A  similar demon- 
stration of this phenomenon can be seen from Text-figs. 19 and 20 which show 
the immunoelectrophoretic patterns formed between the antigens of N1 and T1 
and  trs-150  before and  after absorption with N1  (tris  buffer at pH 8.6).  The 
lone residual  band  of Text-fig.  20  corresponds closely to  those  seen in  Text- 
figs.  5  and  11  prepared from absorbed non-tolerant rabbit antisera.  It should 
be noted that one of the two bands observed on agar gel diffusion between T1 
1-- 
© 
!  { 
(3 
TEXT-FIG. 19.  Immunoelectrophoresis  in agar gel (tris buffer at pH 8.6). Upper well, N1, 
lower well, I71, trough, trs-150. Line drawing is shown because in a number of the bands formed 
were not intense enough to be faithfully reproduced by photography. 
TEx-FIG. 20.  Immunoelectrophoresis  in agar gel (tris buffer at pH 8.6). Upper well, N1, 
lower well, TI, trough, trs-150 absorbed with N1. A single residual band developed between 
T1 and trs-150 absorbed with N1. 
and  trs-150  absorbed  with  N1  (Text-fig.  18)  could  not  be  demonstrated  by 
immunoelectrophoresis. 
Results of Immunoftuorescent Studies.--Histological  sections through adjacent 
normal  and  tumor  areas  of  the  twelve  specimens  of  adenocarcinoma  of  the 
colon, which had not been included in either of the two tissue pools, were studied 
by the indirect  or  "sandwich"  technique.  The test antisera used in each case 
included  nl,  n2,  tx,  t2,  the  various  absorbed  preparations  of  these  sera,  and 
trs-150.  The results  obtained with  any given test  antiserum preparation  was 
almost identical  for  each of the  pathological specimens.  Furthermore  no sig- 
nificant differences could be detected between the immunological properties of 
antisera prepared against pool I  antigens or against pool II antigens. 454  TU2~OR- SPECIFIC  ANTIGENS 
Figs.  1 to 9 are representative of such findings. The specimen was removed 
from a patient with adenocarcinoma of the transverse colon. The use of either 
unabsorbed nx or unabsorbed t~ as test antisera resulted in intense staining of 
both tumor tissue  and normal colonic tissue  (Figs.  1 to 4).  When h-abs was 
employed as the test antiserum little or no fluorescence could be found in the 
normal  tissue  areas  (Fig.  5),  whereas  the  tumor  areas  still  showed  strong 
fluorescein labeling (Fig. 6). The degree of fluorescence of the tumor tissue was 
somewhat less  intense than before absorption. After absorption of trabs with 
T1, little or no residual fluorescence could be found in the tumor tissue (Fig. 7). 
Reactions  carried  out  with  trs-150  showed  that  only  a  slight  degree  of 
fluorescence was  imparted  to  the  normal  tissue  areas  (Fig.  8),  whereas  the 
tumor tissue was intensely labeled (Fig. 9). A comparison of Fig. 6 with Fig. 9 
would suggest  that  the serum of the experimental group of animals showing 
TEXT-FIG.  21.  (A) T b  (B)  filtrate of T1 treated with 0.6 M perchloric acid,  (C)  tl-abs. A 
reaction of complete identity can be seen between the two bands formed. 
split and/or partial tolerance to N1 caused stronger labeling than the absorbed 
tumor-specific antiserum originally obtained from non-tolerant animals. 
Preliminary  Characterization of  Tumor-Specific  Antigens  and  Antibodies.- 
Following  treatment  of  T1  with  0.6  ~a  perchloric acid,  the  dialyzed filtrate, 
after concentration to  the original volume of T1 employed, produced a  single 
band  in  agar  gel  against  tvabs.  This  band  showed  a  reaction  of  complete 
identity with the band formed between T1 and trabs  (Text-fig. 21). 
Fractionation of h-abs and trs-150 on a sephadex G-200 column yielded the 
usual 3 peaks (32). The entire antibody activity of each antiserum preparation, 
as determined by agar gel diffusion against T1, was found to be in the second 
(7S)  peak.  The  Ouchterlony patterns  were  identical  to  those  observed with 
whole  h-abs  and  whole  trs-150  against  T1. The  first  (19S)  and  third  (3-4S) 
peaks were totally inactive. Upon treating tvabs and trs-150 with 0.1  ~  mer- 
captoethanol,  Ouchterlony  and  hemagglutination  reactions  against  T1  were 
found to give the same results as had been obtained prior to treatment. 
DISCUSSION 
The  experimental  findings  would  suggest  that  adenocarcinomata  of  the 
human  colon contain  unique  tumor  antigens  which  arc  absent  from normal PHIL  GOLD  AND  SAMUEL  O.  l~EEDMAN  455 
colonic tissue, and are capable of stimulating tumor-specific antibody formation 
in heterologons animals. 
Tumor-specific antibodies were demonstrated by the techniques of agar gel 
diffusion, immunoelectrophoresis, passive cutaneous anaphylaxis, and hemag- 
glutination in antitumor antisera which had been absorbed with normal colonic 
tissue components and pooled human plasma. Other investigators using either 
the absorption technique (9, 10, 36) or other methods (8, 37-41) have obtained 
results essentially similar to those reported here. However, in a critical evalua- 
tion of these and related studies, Southam (42) has pointed out that the results 
must be interpreted with caution "because an adequate normal control tissue 
is seldom  obtainable." This  source  of error was overcome in the present  in- 
vestigation because both normal and tumor tissues were obtained from the same 
donors.  It was  also  shown  in  this  study that  the  tumor-specific antibodies 
demonstrated by the absorption technique were not directed against bacterial 
contaminants or against the unusually high concentrations of fibrin found in 
many neoplastic  tissues  (43-46).  Moreover,  the further adsorption of tl-abs 
and t~-abs on large quantities of lyophylized normal tissue extract (100 mg of 
extract protein/ml antiserum) failed to inhibit the development of the tumor- 
specific band formation between these antisera and the pooled tumor extracts 
(T1  and  T~).  These  observations  strongly  suggest  that  the  tumor-specific 
antigens under consideration are qualitatively tumor-specific and not mere]y 
present in higher concentrations in tumor tissue than in normal tissue. 
Comparison of the apparently single tumor-specific precipitin bands observed 
in agar gel between pool I antigens (T1) and tl-abs and between pool II antigens 
(T2)  and  t2-abs  indicated  that  the  same  antigen-antibody complexes  were 
responsible for the production of both bands. This finding would suggest the 
existence of one or more common tumor-specific antigens in the pool I  and 
pool II tumor aliquots. Furthermore, the immunofluorescent studies provided 
additional evidence for the presence of the same common antigen(s) in twelve in- 
dividual tumor sections which had not been included in either of the two tissue 
pools.  The  qualitative  similarity of  the  tumor-specific antigens  in  the  two 
tissue pools and the twelve individual specimens was demonstrated by the Ouch- 
terlony technique. It may thus be inferred that when normal colonic tissue 
undergoes tumor transformation to adenocarcinoma new antigenic moieties de- 
velop which are identical for each individual tumor. 
It is not possible to conclude from these studies whether the specific  tumor 
antigen(s) found in adenocarcinoma of the human colon are restricted to this 
neoplasm or are present in other human malignancies. The findings of other 
workers are of interest in this respect.  Korosteleva (9)  using antitumor anti- 
serum  absorption  and  complement  fixation techniques  found  that  common 
tumor-specific antigens could be demonstrated in various types of malignant 
tumors obtained from different individuals. There was, however, no antigen 
common to all tumors. In another study, Toolan (47) showed that rat antiserum 456  TUMOR-SPECIFIC  ANTIGENS 
prepared against several human cancer cell lines cross-reacted with the HEp3 
cell line.  Further evidence to support the concept that different tumor types 
may  contain  common antigens  is  obtained from  tissue  culture  cytotoxicity 
studies by Bjorklund (48), and from studies of cancer cell homotransplantation 
in man by Southam and his associates (49, 50). The possibility that the tumor- 
specific  antigen(s)  demonstrated  in  the present  investigation  may occur in 
human neoplasms other than adenocarcinoma of the colon is presently under 
active investigation by the authors. 
The experimental results obtained with the sera of rabbits immlmized  with 
colonic tumor tissue after split and/or partial  tolerance had been induced to 
normal  colonic  antigens  provided  additional  evidence  for  the  presence  of 
tumor-specific  antigens.  The development of incomplete rather than complete 
tolerance  may be attributable  to  a  number  of factors.  The  relatively wide 
species'  difference  between rabbit  and  man  is probably the most important 
single reason for this phenomenon (35).  Furthermore,  since the normal tissue 
used  to  induce  tolerance  contained  numerous  antigenic  components,  it  is 
conceivable that some of these were present in concentrations too low to produce 
the tolerant state  (19, 51).  Finally, it should be noted that the first immune 
response to normal tissue occurred at 100 days. At this point in the immuniza- 
tion schedule, the animals  had already received four injections of tumor extract 
(TO emulsified in complete Freund's adjuvant. Paraf (52) has postulated that 
Freund's  adjuvant  in  addition  to  its  well  established  action  of stimulating 
antibody production, may be instrumental in breaking immunological  tolerance 
or paralysis  in  previously suppressed  animals.  The  suggested mechanism  is 
the increased proliferation of antibody producing cells beyond the availability 
of antigen required to suppress the newly formed cells. 
Despite the failure to induce complete immunological  tolerance to the normal 
tissue  extract  (NO,  the  degree of suppression  of the  immune  response  was 
sufficient to demonstrate the presence of specific tumor antigens in the tumor 
tissue extract (TO. For example,  when the pooled serum of the immunologically 
suppressed animals  was tested by agar gel diffusion, passive cutaneous anaphy- 
laxis, or hemagglutination,  more intense reactions were noted against T1 than 
against Nx. 
Comparison of the tumor-specific antibodies found by the use of the tolerance 
technique  with  those found  by the  absorption  technique  is  of considerable 
interest. Agar gel diffusion  studies revealed six bands between T1 and trs-150 
(Text-fig.  17). Of these six bands, two showed reactions of identity with the 
two bands between N1 and trs-150, and thus represented antigenic components 
common to normal and tumor tissue. Another two of the six bands between T1 
and  trs-150  showed reactions  of identity with  the apparently  single  tumor- 
specific band between T~ and trabs suggesting  that the latter band, although 
apparently  single,  consisted  of  at  least  two  antigen-antibody  complexes. 
However, immunoelectrophoretic  study of  T~  against  trabs  yielded only a PHIL  GOLD AND  SAMUEL  O. ]FREEDMAN  457 
single band (Text-fig.  5). It is possible that the failure to demonstrate a second 
band  by immunoelectrophoresis  may  have  been  due  to  a  relatively  small 
absolute quantity of one or more of the tumor antigens in the volume of tumor 
extract used in this procedure. An alternative explanation is that the tumor- 
specific precipitin reaction between T1 and h-abs involved only a single anti- 
genic molecule containing two or more tumor-specific  antigenic determinants. 
Thus far, four of the six precipitin bands have been accounted for, leaving two 
apparently tumor-specific  precipitin bands between T1 and trs-150 which were 
not  observed with  the  absorbed antisera.  This  demonstration  of additional 
tumor-specific antibody activity in trs-150 as compared with h-abs was further 
confirmed by immunofluorescent, passive cutaneous anaphylaxis, and hemag- 
glutination experiments. Since the same antigenic material, T~, was used to im- 
munize both groups of animals,  the presence of additional tumor-specific  anti- 
body activity in trs-150 must be adequately explained. 
One possible explanation is that  the non-tolerant  animals  irnmuniza~d with 
T~ failed to produce antibodies against certain of the tumor-specific  antigens. 
Such an  occurrence might  be explained  by the phenomenon  of competition 
between antigens or "crowding out" (53).  It has been shown in a number of 
experimental situations  that  exposure of animals  to multiple antigens,  either 
simultaneously or in succession, may lead to the failure of some of the antigenic 
components to stimulate antibody production. In the present study, when the 
non-tolerant  animals  were  injected  with  tumor  tissue  extract,  the  tumor- 
specific  antigens  had  to  compete with  the normal  tissue components of the 
tumor in order to stimulate antibody production.  Thus,  some of the tumor- 
specific  antigens  may have been "crowded out."  However, in  the group of 
immunologicaUy  suppressed  animals,  the  competition  faced by the  tumor- 
specific  antigens  was  greatly  reduced  because  antibody  production  to  the 
normal tissue components of the tumor extract had been markedly suppressed. 
The  second  possible  explanation  for  the  greater  tumor-specific  antibody 
activity of trs-150  as  compared  to  h-abs  is  that  although  the non-tolerant 
animals  produced antibodies  to  all  the  antigenic  components unique  to  the 
tumor material, some of these may have been removed during the absorption 
procedure with  normal  tissue  extract  and pooled human plasma.  The latter 
hypothesis is probably the more important,  since  absorption of trs-150  with 
normal  tissue  extract  reduced  its  tumor-specific  antibody activity  to  levels 
comparable to that of h-abs. 
Therefore it may be concluded that,  under  the  conditions  of the present 
experiment, more tumor antigens were demonstrated by the tissue tolerance 
technique than by the absorption method. Whether these additional antigens 
are qualitatively different from normal tissue antigens (54), or merely present 
in tumor tissue in higher  concentrations than in normal tissue has not as yet 
been determined. 
The results of sephadex G-200 fractionation of h-abs and  trs-150  indicate 458  TUMOR-SPECIfIC ANTIGENS 
that the tumor-specific antibodies have sedimentation coefficients of about 75. 
This conclusion is supported by the failure to reduce tumor-specific antibody 
activity following treatment with 0.1 ~ mercaptoethanol. Extraction of TI with 
0.6 ~  perchloric acid and agar gel diffusion study of the filtrate revealed that 
at least part  of the tumor-specific antigenic preparation was mucoprotein in 
nature. Previous investigations of other tumor systems (55) have also suggested 
abnormalities of tumor tissue mucoprotein components. 
Because  it  was  found  that  one  or  more  of  the  tumor-specific antigenic 
determinants might be polysaccharide in nature, and since the conventional 
BDB hemagglutination technique (24) failed to correlate with results of the 
other serological  tests,  this procedure was slightly modified (56).  During the 
process of erythrocyte sensitization, the BDB was mixed with the rabbit cells 
immediately before, rather than after the addition of antigen. The reasons for 
this change become apparent, if it is remembered that the BDB hemagglutina- 
tion technique was originally developed for use with protein antigens (56) which 
are coupled to erythrocytes through stable covalent linkages with their his- 
tidine and tyrosine groups. However, it is well known that antigens containing 
carbohydrates (e.g. bacterial polysaccharides or tannic acid) may coat red cells 
directly and non-specifically (57, 58). It was felt that if a number of important 
determinants of the tumor-specific antigens were polysaccharide in nature, then 
the  addition of BDB  after  the  antigenic material had been mixed with the 
erythrocytes would allow some, or all, of the immunologically active groupings 
to  be  non-specifically adsorbed  onto  the  red  cells.  The  determinant groups 
would then be unavailable for union with antibody. However, if the BDB were 
added to the red cells immediately before  the addition of antigen, competition 
would occur  between various portions of the antigen molecules to determine 
which would link to  the red  cell.  The  histidine and  tyrosine of the protein 
portion of the molecule would tend to conjugate to the red cell through the 
BDB linkage, while the non-protein antigenic determinants would be left free 
to take part in the hemagglutination reaction. The results obtained (compare 
titers A and B in Tables II and III) would indicate that the proposed mechanism 
did indeed predominate.  It  would therefore seem probable  that  the  tumor- 
specific  antigens,  although  containing  protein  components  probably  have 
polysaccharide determinants of great importance. 
SU~'M AR¥ 
Two  methods  were  used  to  demonstrate  the  presence  of  tumor-specific 
antigens in adenocarcinomata of the human colon: (a) rabbits were immunized 
with extracts of pooled colonic carcinomata, and the antitumor antisera thus 
produced were absorbed with a pooled extract of normal human colon and with 
human blood components;  (b)  newborn  rabbits  were made immunologically 
tolerant to normal colonic tissue at birth, and were then immunized with pooled PHIL  GOLD  AND  SAMUEL  0.  FREEDMAN  459 
tumor material in adult life. Normal and tumor tissues were obtained from the 
same human donors in order to avoid misinterpretation of results due to indi- 
vidual-specific antigenic  differences. 
The antisera prepared by  both  methods  were  tested  against  normal  and 
tumor antigens by the techniques of agar gel diffusion, immunoelectrophoresis, 
hemagglutinafion, PCA, and immunofiuorescence. Distinct antibody activity 
directed against  at  least  two  qualitatively  tumor-specific antigens,  or  anti- 
genic determinants, was detected in  the  antisera prepared by both methods 
and at least two additional tumor antigens were detected exclusively in anti- 
sera prepared by the tolerance technique. Whether these additional antigens 
were qualitatively  different  from  normal  tissue antigens,  or merely present 
in tumor tissue in higher concentrations than in normal tissue has not as yet 
been  determined.  Furthermore,  it  was  shown  that  the  tumor-specific anti- 
bodies were not directed against bacterial contaminants or against the unusu- 
ally high concentrations of fibrin found in many neoplastic tissues. 
It was concluded from these results that the pooled tumor extracts contained 
tumor-specific antigens not present in normal colonic tissue.  Identical tumor- 
specific antigens  were  also  demonstrated in  a  number  of individual  colonic 
carcinomata obtained from different human  donors. 
The authors wish to express  their thanks to Miss J. Jonson for invaluable technical assist- 
mace, and to Mr. H. Artinian of the Department of Medical Photography, Montreal General 
Hospital for his aid in the preparation of figures and plates. 
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EXPLANATION OF PLATES 
PLATE 35 
FIG. 1.  Section of normal area of colon treated with nl. Intense fluorescence can be 
seen throughout the tissue.  X  100. 
FIG. 2.  Section of tumor area of colon treated with nl. The intensity of fluorescence 
seen  indicates  a marked degree  of cross-reactivity between some normal tissue  and 
tumor tissue  antigens.  (Compare staining intensity with that of Fig.  5 and Fig.  7). 
×  100. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  35 
(Gold and Freedman: Tumor-specific antigens) PLATE  36 
FIG. 3.  Section of normal area of colon treated with tl. The degree of the fluorescein 
label taken up by the normal tissue suggests marked  cross-reactivity between some 
normal tissue and tumor tissue antigens.  X  100. 
FIC. 4.  Section of  tumor area of colon treated with tm. Diffuse fluorescence is seen 
throughout the tumor area.  X  100. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  36 
(Gold and Freedman: Tumor-specific antigens) PLATE 37 
F~G.  5.  Section  of  normal  colon  treated  with  h-abs.  Little  fluorescein  labeling 
remains, indicating that  ti-abs contains no demonstrable antibodies against normal 
colonic components. X  100. 
F~G. 6.  Section  through  colonic  tumor  area  treated  with  t~-abs. The  degree  of 
fluorescent intensity is less marked than in Fig. 4 but remains very distinct, revealing 
the presence  of tumor-specific  components in tt-abs.  ×  10/). TI-IE JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  37 
(Gold and Freedman: Tumor-specific antigens) PLATE 38 
FIO. 7.  Section of  tumor area  treated with tl-abs further absorbed with TI. The 
absence of any significant fluorescence in this section indicates the specific inhibition 
of the tumor-specific  antibody activity of tl-abs by the tumor extract T1.  ×  100. 
FIG. 8.  Section of normal colon treated with trs-150.  Only a slight degree  of fluo- 
rescein labeling is observed.  X  100. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  121  PLATE  38 
(Gold and Freedman: Tumor-specific antigens) PLATE 39 
Fro.  9.  Section of  tumor area  treated  with  trs-150.  Intensity of  fluorescence  as 
compared with Fig. 8 indicates much greater antitumor than antinormal activity of 
trs-150.  Comparison  with Fig 6 suggests  greater antitumor activity of trs-150 than 
t-abs.  X  100. TIlE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  39 
(Gold and Freedman: Tumor-specific antigens) 